Chris Patil (@donotgogently) 's Twitter Profile
Chris Patil

@donotgogently

Biologist of aging. VP-Media at @bioagelabs. Producer and co-host of @bioagepodcast. Tweets, politics, & memes are my own. (he/him)

ID: 20000164

calendar_today03-02-2009 20:17:59

17,17K Tweet

2,2K Followers

1,1K Following

Chris Patil (@donotgogently) 's Twitter Profile Photo

Is there any functional reason to tag 'channel' in Slack, or is it the equivalent of jumping up and down while already raising your hand

Chris Patil (@donotgogently) 's Twitter Profile Photo

My interview with Dr. Khan was educational to say the least, giving me a new perspective on the mission of this incredible organization. Check out the episode!

Chris Patil (@donotgogently) 's Twitter Profile Photo

Congratulations to my dear friend (and college/grad school roommate!) Steve McCarroll for being named an HHMI Investigator! Well deserved! hhmi.org/news/hhmi-inve… (congrats to the other 25 new investigators as well)

BioAge (@bioagelabs) 's Twitter Profile Photo

BioAge is pleased to announce initiation of the STRIDES Ph2 clinical trial of azelaprag, an oral exercise mimetic, for obesity—a milestone in our mission to develop new therapies for metabolic diseases by targeting the biology of aging. businesswire.com/news/home/2024… More below! (🧵)

Longevity SF (@longevitysf) 's Twitter Profile Photo

This Monday (9/30), join us in SF for a night about brain aging and what we are doing about it. I will be speaking as will Reneu Bio CEO, Salah Mahmoudi, and Chris Patil will be moderating. RSVP: lu.ma/90qqi0eu Thanks to BioAge for sponsoring!

BioAge (@bioagelabs) 's Twitter Profile Photo

We are thrilled to announce the closing of BioAge's IPO! As of September 26, we are trading on Nasdaq as $BIOA. This milestone will enable our development of novel therapies that treat metabolic diseases by harnessing the biology of aging. (1/3)

We are thrilled to announce the closing of BioAge's IPO! As of September 26, we are trading on Nasdaq as $BIOA. This milestone will enable our development of novel therapies that treat metabolic diseases by harnessing the biology of aging. (1/3)
Stephan J. Guyenet (@sguyenet) 's Twitter Profile Photo

This theory makes a lot of sense to me. The reason some thin people are making moral arguments against GLP-1s is that, on some level, they think the drugs degrade the status signal of being lean (that they benefit from).

Chris Patil (@donotgogently) 's Twitter Profile Photo

Such a pleasure to host Michael Ringel, JD PhD on the BioAge podcast this week - his unique combination of deep knowledge of aging science and broad perspective on biopharma is always illuminating, and I really enjoyed the conversation!

BioAge (@bioagelabs) 's Twitter Profile Photo

"Of all the things we know about, the one that rises to the very top is exercise. In fact, it's the only intervention in people that has shown any effect on slowing the body-wide aging clock," says cardiologist and author Eric Topol in the Washington Post. This is exactly why

David Pfau (@pfau) 's Twitter Profile Photo

We desperately need to take all the people in SF who talk about accelerating biology but have only ever done math or CS and have them do a six month rotation in a wet lab.

Chris Patil (@donotgogently) 's Twitter Profile Photo

Had an absolute blast moderating this panel at the Bay Area Aging Meeting! 🧬 Six brilliant minds and one big question: how do we get longevity science out of the lab and into patients' lives? As I say in the episode: hosting this podcast is an honor and a joy.